Seeking Alpha

EntreMed (ENMD +8%) gets a pop today after announcing earlier that it has initiated a second...

EntreMed (ENMD +8%) gets a pop today after announcing earlier that it has initiated a second site at Indiana University for its Phase 2 study of ENMD-2076 in triple-negative breast cancer. Initial studies, supported by a grant from the National Cancer Institute, are already underway at the University of Colorado Cancer Center.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|